North Western Deanery, Manchester, UK.
University Hospital of South Manchester NHS Foundation Trust, Manchester, UK.
Anaesthesia. 2015 Nov;70(11):1274-80. doi: 10.1111/anae.13211. Epub 2015 Sep 8.
Ventilator-associated pneumonia is a common healthcare-associated infection with significant mortality, morbidity and healthcare cost, and rates have been proposed as a potential quality indicator. We examined ventilator-associated pneumonia rates as determined by different diagnostic scoring systems across four adult intensive care units in the North West of England. We also collected clinical opinions as to whether patients had ventilator-associated pneumonia, and whether patients were receiving antibiotics as treatment. Pooled ventilator-associated pneumonia rates were 36.3, 22.2, 15.2 and 1.1 per 1000 ventilator-bed days depending on the scoring system used. There was significant within-unit heterogeneity for ventilator-associated pneumonia rates calculated by the various scoring systems (all p < 0.001). Clinical opinion and antibiotic use did not correlate well with the scoring systems (k = 0.23 and k = 0.17, respectively). We therefore question whether the ventilator-associated pneumonia rate as measured by existing tools is either useful or desirable as a quality indicator.
呼吸机相关性肺炎是一种常见的医疗保健相关感染,具有显著的死亡率、发病率和医疗成本,并且其发生率已被提议作为一种潜在的质量指标。我们研究了英格兰西北部四个成人重症监护病房使用不同诊断评分系统确定的呼吸机相关性肺炎发生率。我们还收集了临床医生对患者是否患有呼吸机相关性肺炎以及是否接受抗生素治疗的意见。根据使用的评分系统,呼吸机相关性肺炎的发生率分别为每 1000 个呼吸机床日 36.3、22.2、15.2 和 1.1。各种评分系统计算的呼吸机相关性肺炎发生率在各单位之间存在显著的异质性(均 p < 0.001)。临床意见和抗生素使用与评分系统相关性不佳(分别为 k = 0.23 和 k = 0.17)。因此,我们质疑现有工具测量的呼吸机相关性肺炎发生率作为质量指标是否有用或可取。